Cosmos Health Inc. issued a press release and CEO letter announcing preliminary expectations for its fourth fiscal quarter ending December 31, 2026. The company expects U.S. revenue to reach approximately $15 million, driven by subscription growth that increased 42% in five days to 8,940 active subscriptions. This growth supports an expected gross profit of $10.5 million at a 70% margin. Additionally, the CEO reaffirmed full-year 2026 revenue guidance to surpass $90 million and provided long-term targets for 2029. Cosmos Health Inc. operates as a diversified, vertically integrated global healthcare group involved in pharmaceutical manufacturing, distribution, proprietary brands, and direct-to-consumer e-commerce.
